Clinerion Ltd Contact Details:
Main address: Margarethenstrasse 47 4053 Basel, Switzerland ,
Tel:+41 61 865 60 60 , E-mail: info(at)clinerion.com Website:

Clinerion Patient Network Explorer

Clinerion Patient Network Explorer

Optimized study design, precise site selection and faster patient search and identification for clinical research - in real time.

Clinerion Cookie Policy

Welcome to the Clinerion website. This website uses cookies. These cookies are used on your browser to understand how you are using our website. Using this website means you agree to our use of cookies. If you prefer not to have these cookies on your device, we advise you to disable them in your web browser settings. You accept the use of cookies by accepting this notice. You can read more details via our Privacy Policy page.

Privacy Policy page >


White Papers, Publications & Posters

Go deeper into how Clinerion can support you.



Identifying undiagnosed rare disease patients by modelling disease-specific phenotypes using EHR data (White Paper)

April, 2022

Alleviating the suffering of rare disease patients caused by incorrect diagnosis through use of Clinerion’s Patient Network Explorer, global patient data network and AI/ML technologies.

Rare diseases, by nature of being rare, often go undiagnosed or are misdiagnosed, and for these reasons, rare disease patients may not receive the right treatment. For many rare diseases – and there are currently more than 6,000 – there is strong evidence that at least 50% of patients are never correctly diagnosed due to heterogeneous presentation, lack of medical expertise in recognizing symptoms and limited access to the specific diagnostic tests required. Rare diseases often present with different symptoms, which can cause a significant delay in diagnosis; this situation affects not only the patient, but also the family, health care providers and social support structure.

This white paper presents Clinerion's work on identifying undiagnosed rare disease patients by modelling disease-specific phenotypes through use of Clinerion’s Patient Network Explorer, global patient EHR network and AI/ML technologies.

Access the White Paper >



Report: "Industry Clinical Trials In Poland. Possibilities to increase number and scope of trials in Poland"

February, 2022

Did you know that Clinerion has significant coverage in Poland? We recently contributed to the report "Industry Clinical Trials in Poland."

"Industry Clinical Trials in Poland. Possibilities to increase number and scope of trials in Poland." is a report sponsored by the Polish Association of Innovative Pharmaceutical Companies (INFARMA) and the Polish Association for Employers of Contract Research Organizations (POLCRO). Clinerion was invited to contribute a chapter on "Harnessing the Power of Electronic Health Records to Increase Speed and Precision of Clinical Trials."

Download the report here (page is in Polish, but an English language report is available) >

 



Clinical Research & Healthcare Digitalization in the Middle East & Turkey (Publication: Clinical Research at MENA)

February, 2022

Everything you need to know about clinical research & healthcare digitalization in the Middle East & Turkey: read our chapter, by Barış Erdoğan and Le Vin Chin, in the new book on the challenges & solutions of Clinical Research at MENA, by Fatih Özdener!

"The meaning of Clinical Trials for humans has recently changed significantly, “evolved”, so to speak. In today’s environment, where ethical validity is much more strictly controlled, this meaning is far beyond “human drug testing” and much closer to the “therapeutic goal”. The number of clinical trials in western countries that have perceived this change has increased rapidly and continues to increase. Although the number of clinical studies in the MENA region is increasing day by day, it is still far from its potential. Among the reasons for this are legal, technological, ethical, epidemiological, educational and economic factors. This book presents both the difficulties encountered in conducting clinical trials in MENA and
suggestions for solving these difficulties."

Fatih Özdener has broad pharmaceutical industry experience at different local and regional medical functions including clinical operations, clinical quality and medical management in Turkey, Middle East and Africa. He has more than twenty publications in the fields of molecular and clinical pharmacology. Currently, he is a faculty member and a member of management board at Bahcesehir University School of Medicine and the program coordinator of Pharmaceutical Medicine master’s degree program at the same university.

More details and ordering >



The Clinerion Technology Vision for RWD Insights (White Paper)

October, 2021

Enabling a full digital patient profile from EHR to enhance physician access, clinical research, and patient care.

As the volume of both clinical trial and real-world data continues to grow exponentially, the pharma industry is struggling to deal with data interoperability issues and generate actionable insights. There is a critical need to address concerns around data standardization, data security, data ownership and to build robust data governance models to enable data integration.

This white paper presents Clinerion's vision for the future of technology for real-world data insights, addressing these topics and also touching upon evolving models such as data fabrics, federated learning platforms and digital ecosystems.

Access the White Paper >



Patient Population Analytics (Posters)

July, 2021

Clinerion’s Patient Network Explorer offers indication-agnostic access to live, real-world, anonymized, aggregate EHR data of its partner hospitals.

More details and example reports on Multiple Myeloma in Turkey & Asthma, FeNO ≥20 ppb in the UAE >



Can real world data support drug development with better trial design and real-world evidence? (Poster)

June, 2021

Our work with our partner Datametrix uncovers how use of statistical analytics methodologies on electronic health records can build synthetic control arms to supplement clinical trial data for better clinical and regulatory decisions.

Find out more and access the poster >



Strategies Toward Identifying Undiagnosed Rare Disease Patients (Poster)

April, 2021

Strategies Toward Identifying Undiagnosed Rare Disease Patients

In this poster, produced together with Volv Global and originally presented at the Frontiers in Pediatric Genomic Medicine Conference (April, 2021), we explore how EHR-based real world data enables the ability to find potential patients that have been diagnosed as well as those that have not been correctly diagnosed.

The poster explains how EHR systems can be used to identify existing diagnosed patients, to identify undiagnosed patients through related symptoms, and to model more heterogenous disease response using an AI/ ML approach to find patients yet undiagnosed.

Download the poster >



Accessing Multiple Patient Data Sources to Enhance Generation of Real-World Evidence, Outcomes Research & Non-Research Evaluations (Poster)

September, 2020

The poster explains how Clinerion’s ecosystem allows the interrogation of retrospective data, as well as the generation of new prospective data for RWE studies, surveillance, sentinel and cross-sectional studies, feasibility studies, screening for risk management or health-care system evaluation, among other traditional or innovative study designs.

Download the poster >